Greenland Mines Ltd GRML

$6.38 -0.96 (-13.08%)

Valuation

Market cap
97,967,000
Revenue TTM
$0
Net income TTM
$-10,550,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
4,843,800
Avg volume
9,996,224
Day's range
$6.05 – $7.54
Shares out
13,347,000
Stochastic %K
3%
Beta
6.26
Analysts
Strong Buy
Price target
—

Price

Company profile

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gen...

Show more

Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.

Industry
Other Precious Metals & Mining
Sector
Basic Materials
Phone
833 931 6330
Website
https://greenlandmines.com
Address
1300 South Boulevard, Unit D, Charlotte, United States

Latest news